Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors

Clinical trial NCT06932094 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06932094
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-05-01
Primary completion: 2027-05-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.